Does Nonalcoholic Fatty Liver Disease Predispose Patients to Hepatocellular Carcinoma in the Absence of Cirrhosis?

被引:18
作者
Guzman, Grace [1 ]
Brunt, Elizabeth M. [3 ]
Petrovic, Lydia M. [4 ]
Chejfec, Gregorio [1 ]
Layden, Thomas J. [2 ]
Cotler, Scott J. [2 ]
机构
[1] Univ Illinois, Dept Pathol, Chicago, IL 60614 USA
[2] Univ Illinois, Dept Med, Chicago, IL USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[4] NYU, Dept Pathol, Med Ctr, New York, NY 10016 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Hepatocellular carcinoma (HCC) is recognized as a complication of cirrhosis related to nonalcoholic fatty liver disease (NAFLD). Diabetes and the metabolic syndrome are also associated with HCC. However, it is not clear whether NAFLD predisposes patients to HCC in the absence of cirrhosis. Objective.-To seek evidence that HCC can develop in NAFLD unaccompanied by cirrhosis. Design.-Retrospective case study was performed on cases from 2004 to 2007 at the University of Illinois at Chicago Medical Center, using the key words hepatocellular carcinoma, liver explant, and liver resection. The diagnosis of HCC was identified and confirmed by hematoxylin-eosin-stained slides in 50 cases. Cause of liver disease was determined by review of liver histology, clinical history, and laboratory data. Results.-Three patients presented with advanced HCC with features of metabolic syndrome, including an elevated body mass index. Each patient had bland steatosis on liver biopsy, without fibrosis or cirrhosis. None of the 3 patients had evidence of any cause for liver disease other than NAFLD. Conclusions.-The cases presented here suggest that NAFLD may predispose patients to HCC in the absence of cirrhosis. Further studies are needed to confirm this potentially important observation.
引用
收藏
页码:1761 / 1766
页数:6
相关论文
共 39 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   Liver extracellular matrix in health and disease [J].
Bedossa, P ;
Paradis, V .
JOURNAL OF PATHOLOGY, 2003, 200 (04) :504-515
[3]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[4]  
Brunt EM, 2004, SEMIN LIVER DIS, V24, P3
[5]  
Bugianesi E, 2007, Clin Liver Dis, V11, P191, DOI 10.1016/j.cld.2007.02.006
[6]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[7]   Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma [J].
Bullock, RE ;
Zaitoun, AM ;
Aithal, GP ;
Ryder, SD ;
Beckingham, IJ ;
Lobo, DN .
JOURNAL OF HEPATOLOGY, 2004, 41 (04) :685-686
[8]   Obesity and hepatocellular carcinoma [J].
Caldwell, SH ;
Crespo, DM ;
Kang, HS ;
Al-Osaimi, AMS .
GASTROENTEROLOGY, 2004, 127 (05) :S97-S103
[9]   Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma [J].
Cuadrado, A ;
Orive, A ;
García-Suárez, C ;
Domínguez, A ;
Fernández-Escalante, JC ;
Crespo, J ;
Pons-Romero, F .
OBESITY SURGERY, 2005, 15 (03) :442-446
[10]   HCV-ASSOCIATED LIVER-CANCER WITHOUT CIRRHOSIS [J].
DEMITRI, MS ;
POUSSIN, K ;
BACCARINI, P ;
PONTISSO, P ;
DERRICO, A ;
SIMON, N ;
GRIGIONI, W ;
ALBERTI, A ;
BEAUGRAND, M ;
PISI, E ;
BRECHOT, C ;
PATERLINI, P .
LANCET, 1995, 345 (8947) :413-415